Research across Obstetric Labor Complications
Related studies from across the Obstetric Labor Complications family.
22 trials tracked for Premature Birth: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 14 citations.
Showing the 22 most-cited and recently-updated of 22 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Vaginal Progesterone is established as an intervention for the management of premature birth, with reported outcomes showing 29 cases of preterm birth <37 weeks and 9 cases of preterm birth <34 weeks in one cohort 1. Additionally, 17-Hydroxyprogesterone Capronate was evaluated for mean trough levels across multiple gestational windows (20-22, 27-29, and 34-36 weeks) 3.
Other established interventions include the use of Surfactant 4 and palivizumab 5. Additionally, a 13-valent pneumococcal conjugate vaccine was shown to result in high rates of infants achieving serotype-specific Pneumococcal IgG antibody levels (ranging from 72.73% to 98.97%) one month after the infant series 2.
AI synthesis of 6 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Obstetric Labor Complications family.